ArticlemSphere2025
Sensitive, non-invasive detection of chronic wasting disease in wild and captive white-tailed deer using fecal volatile profiling.
Article in mSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Chronic wasting disease (CWD) is a universally fatal, transmissible prion disease affecting cervids. Primarily found among deer populations in North America, the disease has spread across the continent and made forays into Europe and Asia as well. Currently, accurate methods for detecting CWD infection require postmortem dissection of the lymph nodes and brainstem of affected animals. New, high-sensitivity methods of identifying CWD in living animals are sorely needed to help curb the spread of this devastating disease in captive and wild deer. Here, we use two-dimensional gas chromatography-mass spectrometry (GCxGC-MS) to detect volatile organic compounds (VOCs) released from feces of white-tailed deer (WTD) for differentiation of the feces of CWD-negative and CWD-positive animals. We report 4 discrete VOCs in captive WTD and 10 discrete VOCs in wild WTD, with which we can discriminate CWD-positive and CWD-negative samples. Additionally, we evaluate the ability to detect biomarkers associated with CWD early during disease progression, by comparing samples from the early stage of infection with samples from the late stage and uninfected WTD. Our data suggest that detection of VOCs from the feces of WTD-both in captive and wild populations-can serve as a highly sensitive and non-invasive technique for identifying CWD infection in living animals.IMPORTANCEChronic wasting disease (CWD) is a deadly, transmissible prion disease of cervids. The spread of CWD is increasing among both wild and captive deer populations; however, the options to detect in living animals are limited. Diagnosing CWD early would allow more effective control over the spread between animals and contamination of the environment. Our research presents a method of determining CWD infection through the detection of disease-associated odor molecules in the feces of affected deer. This methodology lays the foundation for rapid, non-invasive diagnosis of CWD in living white-tailed deer, allowing for the development of tools to enhance control of this devastating disease's spread among both captive and wild populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.